Reuters logo
Sanofi says Zaltrap approved in Europe for colorectal cancer
February 5, 2013 / 6:20 AM / 5 years ago

Sanofi says Zaltrap approved in Europe for colorectal cancer

PARIS, Feb 5 (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer.

The approval came after a recent late-stage study of the drug showed significant improvement in survival among patients with colon cancer.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below